Melissa M. Hudson

58.4k total citations · 11 hit papers
760 papers, 34.5k citations indexed

About

Melissa M. Hudson is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melissa M. Hudson has authored 760 papers receiving a total of 34.5k indexed citations (citations by other indexed papers that have themselves been cited), including 573 papers in Pediatrics, Perinatology and Child Health, 366 papers in Public Health, Environmental and Occupational Health and 127 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melissa M. Hudson's work include Childhood Cancer Survivors' Quality of Life (566 papers), Acute Lymphoblastic Leukemia research (310 papers) and Family Support in Illness (120 papers). Melissa M. Hudson is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (566 papers), Acute Lymphoblastic Leukemia research (310 papers) and Family Support in Illness (120 papers). Melissa M. Hudson collaborates with scholars based in United States, Canada and Netherlands. Melissa M. Hudson's co-authors include Leslie L. Robison, Kevin C. Oeffinger, Kirsten K. Ness, Wendy M. Leisenring, Gregory T. Armstrong, Deo Kumar Srivastava, Charles A. Sklar, Kevin R. Krull, Daniel M. Green and Ann Mertens and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Melissa M. Hudson

722 papers receiving 33.8k citations

Hit Papers

Chronic Health Conditions... 2003 2026 2010 2018 2006 2013 2003 2013 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chronic Health Conditions in Adult Survivors of Childhood Cancer
    2006 2.6k citations Kevin C. Oeffinger, Charles A. Sklar et al. profile →
  2. Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
    2013 877 citations Melissa M. Hudson, Kirsten K. Ness et al. profile →
  3. Health Status of Adult Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
    2003 626 citations Melissa M. Hudson profile →
  4. Survivors of childhood and adolescent cancer: life-long risks and responsibilities
    2013 587 citations Leslie L. Robison, Melissa M. Hudson profile →
  5. Aging and Risk of Severe, Disabling, Life-Threatening, and Fatal Events in the Childhood Cancer Survivor Study
    2014 398 citations Gregory T. Armstrong, Toana Kawashima et al. Journal of Clinical Oncology profile →
  6. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
    2016 390 citations Gregory T. Armstrong, Yutaka Yasui et al. profile →
  7. Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
    2013 388 citations Louis S. Constine, Melissa M. Hudson et al. profile →
  8. American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
    2013 353 citations Ravi Bhatia, Kevin C. Oeffinger et al. Journal of Clinical Oncology profile →
  9. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
    2015 341 citations Saro H. Armenian, Melissa M. Hudson et al. profile →
  10. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
    2013 319 citations Daniel M. Green, Deo Kumar Srivastava et al. profile →
  11. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
    2023 77 citations Stephanie B. Dixon, Eric J. Chow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa M. Hudson United States 94 21.3k 13.7k 7.1k 6.1k 5.2k 760 34.5k
Kevin C. Oeffinger United States 81 14.6k 0.7× 9.3k 0.7× 8.3k 1.2× 4.6k 0.8× 4.2k 0.8× 445 26.2k
Charles A. Sklar United States 81 14.2k 0.7× 10.1k 0.7× 4.0k 0.6× 2.8k 0.5× 2.9k 0.6× 274 24.2k
Leslie L. Robison United States 123 34.9k 1.6× 24.3k 1.8× 10.8k 1.5× 9.0k 1.5× 8.4k 1.6× 936 58.3k
Ann Mertens United States 76 12.8k 0.6× 8.7k 0.6× 3.2k 0.5× 3.8k 0.6× 2.6k 0.5× 182 21.1k
Kirsten K. Ness United States 79 12.3k 0.6× 6.6k 0.5× 4.3k 0.6× 3.2k 0.5× 3.0k 0.6× 459 19.4k
Gregory T. Armstrong United States 69 11.1k 0.5× 6.2k 0.5× 3.0k 0.4× 2.8k 0.5× 3.0k 0.6× 495 17.6k
Yutaka Yasui United States 67 10.5k 0.5× 9.0k 0.7× 3.0k 0.4× 2.1k 0.3× 2.6k 0.5× 286 19.2k
Anna T. Meadows United States 82 10.4k 0.5× 7.2k 0.5× 4.2k 0.6× 3.1k 0.5× 4.0k 0.8× 229 22.0k
Joseph P. Neglia United States 70 9.3k 0.4× 6.7k 0.5× 3.5k 0.5× 1.8k 0.3× 3.3k 0.6× 252 18.0k
Marilyn Stovall United States 64 7.4k 0.3× 5.0k 0.4× 2.8k 0.4× 1.5k 0.3× 3.5k 0.7× 161 15.2k

Countries citing papers authored by Melissa M. Hudson

Since Specialization
Citations

This map shows the geographic impact of Melissa M. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa M. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa M. Hudson more than expected).

Fields of papers citing papers by Melissa M. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa M. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa M. Hudson. The network helps show where Melissa M. Hudson may publish in the future.

Co-authorship network of co-authors of Melissa M. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa M. Hudson. A scholar is included among the top collaborators of Melissa M. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa M. Hudson. Melissa M. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mulrooney, Daniel A., Isaac Rhea, Christine Yu, et al.. (2024). Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer. JACC CardioOncology. 6(1). 16–32. 9 indexed citations
3.
Williams, AnnaLynn M., Matthew J. Ehrhardt, Angela Panoskaltsis‐Mortari, et al.. (2024). Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma. Clinical Cancer Research. 30(9). 1822–1832. 2 indexed citations
4.
Williams, AnnaLynn M., Jeanne S. Mandelblatt, Mingjuan Wang, et al.. (2023). Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer. JAMA Network Open. 6(11). e2344015–e2344015. 6 indexed citations
5.
Constine, Louis S., Lawrence B. Marks, Michael T. Milano, et al.. (2023). A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions. International Journal of Radiation Oncology*Biology*Physics. 119(2). 321–337. 8 indexed citations
6.
Howell, Carrie R., Tara M. Brinkman, Matthew J. Ehrhardt, et al.. (2023). The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1021–1029. 3 indexed citations
7.
Srivastava, Deo Kumar, Kevin R. Krull, Melissa M. Hudson, et al.. (2021). Online Platform to Assess Complex Social Relationships and Patient-Reported Outcomes Among Adolescent and Young Adult Cancer Survivors. JCO Clinical Cancer Informatics. 5(5). 859–871. 13 indexed citations
8.
Hudson, Melissa M., Daniel C. Bowers, Cécile M. Ronckers, et al.. (2020). Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors. Journal of Neuro-Oncology. 147(2). 417–425. 6 indexed citations
9.
Ness, Kirsten K., Xiaofei Chi, Aimee Santucci, et al.. (2020). Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report. Cancer Epidemiology Biomarkers & Prevention. 30(1). 123–132. 5 indexed citations
10.
Hayek, Samah, Todd M. Gibson, Wendy M. Leisenring, et al.. (2019). Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 38(3). 232–247. 62 indexed citations
11.
Bhatia, Ravi, Saro H. Armenian, Gregory T. Armstrong, et al.. (2015). Collaborative Research in Childhood Cancer Survivorship: The Current Landscape. Journal of Clinical Oncology. 33(27). 3055–3064. 51 indexed citations
12.
Rosenberg, Shoshana M., Chaya S. Moskowitz, Jennifer S. Ford, et al.. (2015). Health Care Utilization, Lifestyle, and Emotional Factors and Mammography Practices in the Childhood Cancer Survivor Study. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1699–1706. 6 indexed citations
13.
Wilson, Carmen L., Kayla Stratton, Wendy M. Leisenring, et al.. (2014). Decline in Physical Activity Level in the Childhood Cancer Survivor Study Cohort. Cancer Epidemiology Biomarkers & Prevention. 23(8). 1619–1627. 41 indexed citations
14.
Oancea, S. Cristina, James G. Gurney, Kirsten K. Ness, et al.. (2014). Cigarette Smoking and Pulmonary Function in Adult Survivors of Childhood Cancer Exposed to Pulmonary-Toxic Therapy: Results from the St. Jude Lifetime Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 23(9). 1938–1943. 8 indexed citations
15.
Krull, Kevin R., Tara M. Brinkman, Chenghong Li, et al.. (2013). Neurocognitive Outcomes Decades After Treatment for Childhood Acute Lymphoblastic Leukemia: A Report From the St Jude Lifetime Cohort Study. Journal of Clinical Oncology. 31(35). 4407–4415. 243 indexed citations
16.
Krull, Kevin R., Nan Zhang, Aimee Santucci, et al.. (2013). Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. Blood. 122(4). 550–553. 37 indexed citations
17.
Blanco, Javier G., Can-Lan Sun, Wendy Landier, et al.. (2011). Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(13). 1415–1421. 269 indexed citations
18.
19.
Donaldson, Sarah S., Michael P. Link, Howard J. Weinstein, et al.. (2007). Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease. Journal of Clinical Oncology. 25(3). 332–337. 86 indexed citations
20.
Hijiya, Nobuko, John C. Panetta, Yinmei Zhou, et al.. (2006). Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood. 108(13). 3997–4002. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin C. Oeffinger Breakdown of academic impact, for papers by Charles A. Sklar Breakdown of academic impact, for papers by Leslie L. Robison Breakdown of academic impact, for papers by Ann Mertens Breakdown of academic impact, for papers by Kirsten K. Ness Breakdown of academic impact, for papers by Gregory T. Armstrong Breakdown of academic impact, for papers by Yutaka Yasui Breakdown of academic impact, for papers by Anna T. Meadows Breakdown of academic impact, for papers by Joseph P. Neglia Breakdown of academic impact, for papers by Marilyn Stovall
Rankless by CCL
2026